$3.99
1.24% yesterday
Nasdaq, Sep 24, 10:15 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$3.99
-0.26 6.12% 1M
-0.65 14.01% 6M
-0.66 14.19% YTD
-2.77 40.98% 1Y
-1.06 20.99% 3Y
-42.71 91.46% 5Y
-29.01 87.91% 10Y
-29.01 87.91% 20Y
Nasdaq, Closing price Wed, Sep 24 2025
-0.05 1.24%

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.6b
Net debt
$208.7m
Cash
$281.3m
Shares outstanding
352.8m
Valuation (TTM | estimate)
P/E
44.3 | 10.5
P/S
1.7 | 1.7
EV/Sales
2.0 | 2.0
EV/FCF
13.5
P/B
2.2
Financial Health
Equity Ratio
52.2%
Return on Equity
2.3%
ROCE
7.1%
ROIC
5.3%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$799.9m | $814.7m
EBITDA
$161.3m | $282.6m
EBIT
$84.0m | $205.8m
Net Income
$34.6m | $134.5m
Free Cash Flow
$118.4m
Growth (TTM | estimate)
Revenue
3.2% | 2.8%
EBITDA
99.7% | 108.8%
EBIT
391.5% | 212.5%
Net Income
159.0% | 720.7%
Free Cash Flow
86.3%
Margin (TTM | estimate)
Gross
93.7%
EBITDA
20.2% | 34.7%
EBIT
10.5%
Net
4.3% | 16.5%
Free Cash Flow
14.8%
More
EPS
$0.1
FCF per Share
$0.3
Short interest
7.7%
Employees
738
Rev per Employee
$1.1m
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a GoodRx Holdings forecast:

13x Buy
59%
8x Hold
36%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a GoodRx Holdings forecast:

Buy
59%
Hold
36%
Sell
5%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
800 800
3% 3%
100%
- Direct Costs 51 51
13% 13%
6%
749 749
5% 5%
94%
- Selling and Administrative Expenses 460 460
8% 8%
58%
- Research and Development Expense 123 123
8% 8%
15%
161 161
100% 100%
20%
- Depreciation and Amortization 77 77
30% 30%
10%
EBIT (Operating Income) EBIT 84 84
391% 391%
11%
Net Profit 35 35
159% 159%
4%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Negative
Seeking Alpha
9 days ago
GoodRx offers compelling value after a ~50% stock decline over the past 12 months, trading at just 6.1x FY25 adjusted EBITDA despite recent execution challenges. A new Novo Nordisk partnership for Ozempic and Wegovy discounts could attract new users and offset recent guidance cuts and Rite Aid-related headwinds. The company cut its revenue and adjusted EBITDA outlook for FY25, which was widely ...
Neutral
Business Wire
23 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., is riding into new creative territory with the launch of The Savings Wrangler, a groundbreaking brand campaign that aims to bring the company's mission to life in an unforgettable way. Designed to deepen cultural relevance and brand resonance, the campaign introduces a lasso-wi...
Positive
Invezz
about one month ago
Goodrx Holdings Inc (NASDAQ: GDRX) closed roughly 50% higher on August 18th after Bagsværd-headquartered Novo Nordisk (NYSE: NVO) announced a GLP-1 partnership with the healthcare platform. According to the companies' joint press release today, “all strengths of Ozempic and Wegovy are now available to eligible self-paying patients for $499/month through GoodRx.
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 738
Founded 2015
Website investors.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today